Ellen Lubman's most recent trade in Werewolf Therapeutics Inc was a trade of 131,900 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Ellen Lubman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 131,900 | 131,900 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Lubman Ellen | Chief Business Officer | 02 Jan 2024 | 131,900 | 131,900 | - | - | Stock Option (right to buy) | ||
| Werewolf Therapeutics Inc | Ellen Lubman | Chief Business Officer | 03 Jan 2023 | 86,200 | 86,200 | - | - | Stock Option (right to buy) | ||
| Werewolf Therapeutics Inc | Ellen Lubman | Chief Business Officer | 06 Jan 2022 | 51,088 | 51,088 | - | - | Stock Option (right to buy) |